These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22279181)

  • 21. Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint.
    Burkhardt O; Rauch K; Kaever V; Hadem J; Kielstein JT; Welte T
    Int J Antimicrob Agents; 2009 Jul; 34(1):101-2. PubMed ID: 19278835
    [No Abstract]   [Full Text] [Related]  

  • 22. Tigecycline: a review of a new glycylcycline antibiotic.
    Scheinfeld N
    J Dermatolog Treat; 2005; 16(4):207-12. PubMed ID: 16249141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline.
    Pieringer H; Schmekal B; Biesenbach G; Pohanka E
    Ann Hematol; 2010 Oct; 89(10):1063-4. PubMed ID: 20174923
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalanced mortality evidence for tigecycline: 2011, the year of the meta-analysis.
    Verde PE; Curcio D
    Clin Infect Dis; 2012 Aug; 55(3):471-2. PubMed ID: 22511552
    [No Abstract]   [Full Text] [Related]  

  • 26. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Minocycline involvement in two cases of acute pancreatitis].
    Chetaille E; Delcenserie R; Yzet T; Decocq G; Biour M; Andrejak M
    Gastroenterol Clin Biol; 1998 May; 22(5):555-6. PubMed ID: 9762297
    [No Abstract]   [Full Text] [Related]  

  • 28. Tigecycline.
    Prescrire Int; 2007 Dec; 16(92):245. PubMed ID: 18092414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered bioavailability of tacrolimus following intravenous administration of tigecycline.
    Pavan M; Chaudhari AP; Ranganth R
    Am J Kidney Dis; 2011 Feb; 57(2):354. PubMed ID: 21251548
    [No Abstract]   [Full Text] [Related]  

  • 30. Tigecycline: benefits and risks.
    Cai Y; Wang R
    Lancet Infect Dis; 2011 Nov; 11(11):804-5. PubMed ID: 21784707
    [No Abstract]   [Full Text] [Related]  

  • 31. Extensive pigmentation secondary to minocycline treatment of rheumatoid arthritis.
    Assad SA; Bernstein EF; Brod B; James WD
    J Rheumatol; 2001 Mar; 28(3):679-82. PubMed ID: 11296985
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of tigecycline pleurodesis: a comparative experimental study.
    Daddi N; Vannucci J; Maggio C; Giontella A; Bravi I; Marziani F; Capozzi R; Ragusa M; Bufalari A; Puma F
    J Surg Res; 2011 Aug; 169(2):e109-18. PubMed ID: 20934718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines].
    Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL
    Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of effect of extracorporeal membrane oxygenation on tigecycline pharmacokinetics.
    Veinstein A; Debouverie O; Grégoire N; Goudet V; Adier C; Robert R; Couet W
    J Antimicrob Chemother; 2012 Apr; 67(4):1047-8. PubMed ID: 22207598
    [No Abstract]   [Full Text] [Related]  

  • 35. Minocycline-induced cutaneous polyarteritis nodosa.
    Tehrani R; Nash-Goelitz A; Adams E; Dahiya M; Eilers D
    J Clin Rheumatol; 2007 Jun; 13(3):146-9. PubMed ID: 17551382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to say goodbye to minocycline?
    Drug Ther Bull; 2013 May; 51(5):49. PubMed ID: 23635606
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute hepatitis induced by minocycline].
    Castex F; Canva-Delcambre V; Maunoury V; Talbodec N; Wolchies E; Paris JC
    Gastroenterol Clin Biol; 1995; 19(6-7):640-1. PubMed ID: 7590035
    [No Abstract]   [Full Text] [Related]  

  • 38. [Stomatitis, glossitis, and esophagitis in a patient treated with minocycline].
    Heidrich H
    Med Klin (Munich); 2004 Jul; 99(7):396-7. PubMed ID: 15322719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should minocycline be used to treat rheumatoid arthritis?
    Panush RS; Thoburn R
    Bull Rheum Dis; 1996 Apr; 45(2):2-5. PubMed ID: 8901389
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperthyroidism and lupus-like syndrome in an adolescent treated with minocycline for acne vulgaris.
    Benjamin RW; Calikoglu AS
    Pediatr Dermatol; 2007; 24(3):246-9. PubMed ID: 17542873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.